FindTrial
Sign In

The Effect of Preoperative Stellate Ganglion Block on Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting

Can preoperative stellate ganglion block reduce the incidence of new-onset atrial fibrillation after coronary artery bypass grafting?: a randomization controlled pilot trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111966
Enrollment
Unknown
Registered
2025-11-07
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease(CAD)

Interventions

Stellate ganglion bloc group:Ultrasound-guided stellate ganglion block with ropivacaine
Control group:Standard treatment

Sponsors

The First Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age >= 18 years; (2) Scheduled to undergo elective coronary artery bypass grafting (CABG); (3) Having signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) History of prior cardiac surgery or atrial fibrillation ablation; (2) Emergency coronary artery bypass grafting (CABG); (3) Concomitant cardiac procedures (e.g., congenital heart disease repair, left ventricular reconstruction, valve surgery, or aortic surgery); (4) Critical preoperative status requiring mechanical or pharmacological support before CABG; (5) Left ventricular ejection fraction (LVEF) 25%); (8) Severe left atrial enlargement (left atrial anteroposterior diameter >55 mm); (9) Poorly controlled hyperthyroidism; (10) Conditions requiring radiotherapy, chemotherapy, or long-term hormonal therapy; (11) Patients with known clinical contraindications to stellate ganglion block (SGB).

Design outcomes

Primary

MeasureTime frame
postoperative atrial fibrillation(POAF);—

Secondary

MeasureTime frame
cumulative time spent in postoperative atrial fibrillation;the need for antiarrhythmic medications to treat postoperative atrial fibrillation; the need for systemic anticoagulation due to postoperative atrial fibrillation;the need for postoperative electrical cardioversion;the duration of postoperative in-hospital stay;number of POAF;—

Countries

China

Contacts

Public ContactChong Lei

The First Hospital of Air Force Medical University

crystalleichong@126.com+86 186 2901 1362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026